B2M and chronic kidney disease: This study evaluated seven serum biomarkers (BTP, fetuin-A, klotho, uromodulin, ADMA, NGAL and B2M) for their potential to distinguish CKD, AKI and healthy controls in a Pakistani cohort (Fig.1).